Avacta* (AVCT): Act now (CORP) | Tristel* (TSTL): A strong FY 2016 (CORP) | Bioventix* (BVXP): FY 2016 results (CORP) | Elecosoft* (ELCO): SaaS model strengthened through acquisition (CORP) | Lok’nStore* (LOK): NAV up 28% (CORP) | Omega Diagnostics* (ODX): Mid year trading update (CORP) | Mortice* (MORT): Positive trading update (CORP)
17 Oct 2016
Morning Note
Tristel Plc (TSTL:LON), 438 | Bioventix Plc (BVXP:LON), 4,450 | Eleco Plc (ELCO:LON), 92.5 | Lok'nStore Group plc (LOK:LON), 839 | Cambridge Nutritional Sciences PLC (CNSL:LON), 3.4
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note
Tristel Plc (TSTL:LON), 438 | Bioventix Plc (BVXP:LON), 4,450 | Eleco Plc (ELCO:LON), 92.5 | Lok'nStore Group plc (LOK:LON), 839 | Cambridge Nutritional Sciences PLC (CNSL:LON), 3.4
- Published:
17 Oct 2016 -
Author:
Guy Hewett | Mark Paddon | Mark Brewer | Cavendish Research -
Pages:
10
Avacta* (AVCT): Act now (CORP) | Tristel* (TSTL): A strong FY 2016 (CORP) | Bioventix* (BVXP): FY 2016 results (CORP) | Elecosoft* (ELCO): SaaS model strengthened through acquisition (CORP) | Lok’nStore* (LOK): NAV up 28% (CORP) | Omega Diagnostics* (ODX): Mid year trading update (CORP) | Mortice* (MORT): Positive trading update (CORP)